OHI · NYSE · STOCK
Omega Healthcare Investors (OHI) Stock Analysis
$46.57
52W $39.26 – $52.39
61/100
$13.92B
16.1
0.58
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is OHI Bullish or Bearish?
Bullish.
Innellis AI committee rates Omega Healthcare Investors (OHI) Buy with a composite score of 61/100
, based on 6 analysts with 67% agreement.
Last updated August 18, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +13.97 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -6.03 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — current ratio of 0.91 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 16.5% shows genuine earnings power backing the valuation — Value
- Dividend yield of 5.8% pays you to wait — Value
- EPS growing 68.9% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Current ratio of 0.91 is tight -- limited short-term liquidity cushion — Risk
- Bollinger bandwidth of 16.6% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 18, 2026
Overall Committee Score
61/100
Agreement
67%
Analysts
6
Conviction
Contested
Sector Rank
Top 37%
of 78 Real Estate peers
Value Analyst
bullish
63
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 16.5% shows genuine earnings power backing the valuation
Growth Analyst
bullish
79
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 68.9% YoY
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst
bearish
35
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Current ratio of 0.91 is tight -- limited short-term liquidity cushion
Macro Analyst
bullish
80
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
61
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2963.04)
Investment Thesis Evolution
Committee score moved marginally from 61.0 to 61.0.
Comparing 2026-08-17 to 2026-08-18 (1 day apart).
Technical Analysis
RSI (14)
32.1
Neutral
MACD Histogram
-0.548
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$43.50
Resistance
$49.13
Bollinger %B
0.17
Inside Bands
Price vs Moving Averages
EMA 9
$47.25
Below
EMA 21
$48.22
Below
EMA 50
$48.13
Below
EMA 200
$45.84
Above
Fundamental Analysis
Valuation
93
Growth
90
Profitability
79
Financial Health
48
Cash Flow
70
Valuation
P/E Ratio
16.1×
P/B Ratio
2.58×
PEG Ratio
0.21
Dividend Yield
5.78%
52W High
$52.39
52W Low
$39.26
Quality & Growth
ROE
1138.9%
ROA
587.2%
Gross Margin
7196.1%
Operating Margin
6238.9%
Revenue Growth YoY
—
Debt / Equity
0.75
AI Fundamental Assessment
P/E ratio of 16.1 (inexpensive relative to a 15-40x range); Price-to-book of 2.6x; PEG ratio of 0.2 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.4%; Return on assets of 5.9%; Net margin of 66.4%; Gross margin of 72.0%; Current ratio of 0.91 (tight short-term liquidity); Debt-to-equity of 0.75; Free cash flow per share is positive (3.02); Most recent quarter beat estimates by 148.1%; 5 consecutive earnings beats; EPS growth accelerating (-9.1% -> +138.0% QoQ); Average YoY EPS growth of 158.7%; Analyst estimates flat over recent quarters
Get the Full OHI Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →